Statistics

Total Visits

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment48

Select a period of time:

Number of views in the range

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment16

Views

Views
January 20250
February 20250
March 202513
April 20252
May 20251
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
Spain1
Kenya1
United States1
 

Top cities views

Views
Council Bluffs1
Nairobi1